An Objective Pain Score for Chronic Pain Clinic Patients.
Agnes K PaceMelanio BrucetaJohn DonovanSonia J VaidaJill M EckertPublished in: Pain research & management (2021)
Interrater reliability revealed a fair-good agreement between the nurse's and researcher's CBPS scores, weighted kappa values of 0.59 and 0.65, preprocedure and postprocedure, respectively. Concurrent validity showed low positive correlation for the preprocedure measurements, 0.34 (95% CI 0.16-0.50) and 0.47 (95% CI 0.31-0.61), and moderate positive correlation for the postprocedure measurements, 0.68 (95% CI 0.56-0.77) and 0.67 (95% CI 0.55-0.77), for the nurses and researchers, respectively. Construct validity demonstrated an equally average significant reduction in pain from preprocedure to postprocedure, CBPS and NRS median (IQR) scores preprocedure (4 (2-6) and 6 (4-8)) and postprocedure (1 (0-2) and 3 (0-5)), p < 0.001. Discussion. The CBPS has been shown to have interrater reliability, concurrent validity, and construct validity. However, further testing is needed to show its potential benefits over other pain scales and its effectiveness in treating patients with chronic pain over a long-term. This study was registered with ClinicalTrial.gov with National Clinical Trial Number NCT02882971.
Keyphrases
- chronic pain
- pain management
- clinical trial
- end stage renal disease
- primary care
- chronic kidney disease
- newly diagnosed
- healthcare
- randomized controlled trial
- ejection fraction
- systematic review
- mental health
- magnetic resonance
- squamous cell carcinoma
- peritoneal dialysis
- spinal cord injury
- computed tomography
- toll like receptor
- single cell